Label free proteomics for multiple myeloma samples treated with four conditions; Bortezomib, Hydroxychloroquine, combination of the two drugs and control treated with DMSO. the labeled tubes as follow :
Treatment Tube Number
Bortezomib 1
2
3
4
Hydroxyquinone 7
8
9
12
Combination 13
16
17
18
Control 19
20
23
24
[doi:10.25345/C5P26QG4K]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: multiple myeloma, label free, hydroxychloroquine, Bortezomib, RPMI ; DatasetType:Proteomics
|
Principal Investigators: (in alphabetical order) |
Richard Fahlman, University of Alberta, Canada |
| Submitting User: | fahlmanlab |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|